Back

Mediterranean lifestyle for secondary prevention of cardiovascular disease: the MEDLIFE pilot study

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention of cardiovascular disease Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jesus Diaz-Gutierrez

Hospital Juan Ramon Jimenez, Huelva (Spain)

4 More presentations in this session

Presentation thumbnail
An innovative multi-disciplinary cardiometabolic clinic for patients with atherosclerotic cardiovascular disease leads to improved risk factor optimisation compared to standard care
Doctor H. Evans (Gateshead, GB)
Abstract Slides Video
Presentation thumbnail
In-hospital influenza and COVID-19 vaccine availability during acute coronary syndrome boosts vaccination rates and improves outcomes versus out-of-season patients advised post-discharge vaccination
Doctor A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides Video
Presentation thumbnail
Pre-existing cardiovascular disease does not augment the post-acute sequalae of SARS-CoV-2.
Mr J. Smith (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Early predictors of progression of short paroxysmal atrial fibrillation
Associate Professor T. Danilevich (Vinnytsa, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention of cardiovascular disease

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease
thumbnail
Congress Presentation
Healthy dietary patterns for the secondary prevention of cardiovascular diseases: a systematic review and meta-analysis of randomised controlled trials and prospective cohort studies
thumbnail
Congress Presentation
Mediterranean-type diet trajectories and 20-year cardiovascular disease incidence: the ATTICA study (2002-2022)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources